ESMO: Merck & Co Vibostolimab Data Are Another Validation Of TIGIT

Shows Promise Alone And In Keytruda Combo

 
• By Kevin Grogan
Race_Cars_Children
Merck And Roche Jostling For Position In TIGIT Race • Source: Shutterstock

More from Immuno-oncology

More from Anticancer